|
Genetic Considerations
of Diseases and Disorders that Affect
the Oral Cavity
Part II. Oral Cancer
and Developmental Disorders
S.
Michele Robichaux, D.D.S.
CANCER
OF THE ORAL CAVITY
Cancers involve body tissues whose
cells are dividing and growing faster
than cells are dying. The result
of excessive cell growth is an enlarged
mass called a tumor. Cancers may
fail to remain within the boundaries
of normal tissues and therefore
spread or invade surrounding healthy
tissues. Unfortunately, cancer of
the head and neck is diagnosed relatively
frequently. The most common oral
cancers involve the surface tissue
(epithelium) of the mouth and pharynx.
RISKS FACTORS
FOR DEVELOPING ORAL CANCER
Genetic Factors.
Genetic factors involved in the
development of cancer include:
Hereditary
predisposition. An individual
with a hereditary predisposition
for cancer is a person with
an increased likelihood of
developing cancer due to inherited
genes. These inherited genes
make body cells more sensitive
to environmental factors, such
as sunlight and tobacco, and,
therefore change normal body
cells into cancer cells.
Oncogenes. Cancers
can be derived from mutations
in genes that change cell growth
patterns. These genes are called
oncogenes. Such a mutation
in an oncogene can convert
ordinary body cells into cancer
cells. Cancers caused by oncogenes
are not inherited. To date,
scientists have discovered
more than 100 oncogenes, and
several oncogenes have been
associated with cancers of
the head and neck.
Tumor suppressor
genes. Normal tumor suppressor
genes are anti-cancer genes
that slow down or stop growth
of normal body cells. Mutations
of tumor suppressor genes can
also cause the development
of oral and pharyngeal cancers.
Tobacco
and Alcohol. Use of tobacco
and alcohol are the major risk factors
for developing oral cancer. Tobacco
and alcohol contains substances
that are carcinogenic or promote
cancer. Cigarettes smoke and substances
in smokeless tobacco have received
considerable attention as carcinogens
that promote oral cancer. Studies
also indicate that smoking in combination
with consumption of alcohol produces
an even greater risk for oral cancer
than use of either substance alone.
Radiation.
Radiation of high dosage and prolonged
duration can produce cancer. There
is no evidence that routine dental
X-rays are carcinogenic, especially
with today's high speed, low dosage
machines.
Traumatic
irritation. Prolonged irritation
from broken teeth, rough dental
restorations, and ill-fitting dentures
are considered a possible causes
for oral cancer.
Viruses.
Some viruses can cause cancer in
human cells. Studies have indicated
a link to oral cancer with infections
from herpes simplex type- I virus,
Epstein-Barr virus, and human papillomavirus.
DIAGNOSIS AND
EVALUATION
Early diagnosis
is the single factor in successfully
combating oral cancer. Therefore,
it is crucial that the patient seeks
immediate and proper treatment for
the disease. If tissue of the mouth
is suspected to be cancerous, a
biopsy is necessary. A biopsy involves
surgically removing diseased tissue
for microscopic evaluation and diagnosis
by a pathologist.
PRE-CANCEROUS
LESIONS OF THE MOUTH
Pre-cancerous
refers to early changes of normal
cells that are changing into cancer
cells. Recognition of pre-cancerous
tissue of the mouth is an important
role in the diagnosis and prevention
of oral cancer by the dental health
professional. Many times, pre-cancerous
tissue goes unnoticed by an individual
because it is not painful. As a
general rule, pre-cancerous or early
cancers do not heal.
Leukoplakia.
Leukoplakia is a term that describes
a 'white patch' on the surface of
oral tissues. Leukoplakias have
been associated with pre-cancerous
tissues. In general, leukoplakias
are suspected as pre- or early cancer
if the white area cannot be scraped
off the surface tissue and cannot
be attributed to another disease.
Erythroplakia.
Erythroplakia occurs in the
oral cavity as a distinct and well-defined
patch with a bright red and velvety
surface. Erythroplakias are relatively
rare lesions of the oral cavity.
Erythroplakias are almost always
pre-cancerous.
DESCRIPTION
OF SELECTED ORAL CANCERS
Cancers can involve
growth changes to any tissue of
the oral cavity. Cancers of the
mouth may be benign or malignant
tumors. A benign tumor is a mass
limited within a connective tissue
capsule. This type of tumor does
not spread or invade adjacent tissue
and is therefore usually not life-threatening.
A malignant tumor, on the other
hand, is a mass capable of spreading
and invading other healthy tissues
of the body. The spread of cancer
cells occurs by traveling within
the bloodstream or lymph system.
A malignant tumor can then form
additional sites of cancers away
from the original tumor, a
process called metastasis. Malignant
tumors are dangerous and difficult
to control. Well-developed malignant
cancers can be life threatening.
Squamous
Cell Carcinoma. Squamous
cell carcinoma is the most frequently
occurring malignant cancer of the
oral region. This type of cancer
involves cell growth changes of
the surface tissue of the oral region,
the epithelium. Nearly 90% of all
oral cancers are squamous cell carcinomas.
The most frequent location of this
cancer is on the lips, the tongue,
and the floor of the mouth. A chronic
(long-term) mouth ulcer that does
not heal, a lesion attached to deeper
tissues, and a red-velvety lesion
are all suspect squamous cell carcinomas.
If left untreated, squamous cell
carcinomas undergo metastasis and
involve vital organs of the body.
Many times death is the result of
complications to the heart and lungs.
Basal Cell
Carcinoma. Basal cell carcinoma
is a tumor located on the surface
of skin that has hair. Basal cell
carcinomas are associated with prolonged
exposure of skin to the sun. Lesions
initially appear as elevated blisters,
followed by a period of ulceration
and healing. Continued cycles of
blistering, ulcerating, and healing
of the same tissue occurs as deeper
tissues are slowly invaded. Metastasis
of basal cell carcinomas is rare, and survival rate of individuals diagnosed
with basal cell carcinoma is excellent.
Fibromas.
Fibromas are benign tumors
whose cell origin lies in the connective
tissue supporting teeth within tooth
sockets, the periodontal membrane.
Osteomas.
Osteomas are benign tumors
whose cell origin is the bone of
the upper and lower jaw.
Malignant
tumors of connective tissue origin.
Malignant tumors of connective tissue
origin (the periodontal membrane,
bone and cartilage) include fibrosarcomas,
osteosarcomas and chondrosarcomas.
Tumors of
the teeth. Tumors involving
cells of the teeth are termed odontogenic
tumors.
Salivary gland
tumors. Salivary gland tumors
are varied in their degree of malignancy
and tumor cell origin. Salivary
gland tumors can be benign or malignant.
This type of tumor is very rare.
TREATMENT OF
ORAL CANCER
The three major
treatment considerations for oral
cancer include:
- Surgical
removal of diseased tissue.
This is the best management
for treatment of cancer if
possible. The advantages
for surgery are prompt treatment
and the ability of physicians
to study tissue removed during
surgery with a microscope.
With this study, it can be
known that the entire tumor
has been removed. The disadvantage
of surgical treatment is normal
tissue loss in the attempt
to remove all diseased tissue.
Another consequence to surgery
is the risk of loss of function
and cosmetic defects.
- Radiation
therapy. This is an
effective form of treatment
for isolated areas of cancer.
As the size of the tumors enlarge,
larger doses of radiation are
necessary to kill cancer cells.
The advantages of radiation
therapy are the preservation
of normal tissues and the maintenance
of normal tissue function.
The major disadvantage of radiation
therapy includes inflammation
of the lining of the mouth,
destruction of salivary gland
tissue that can result in dry
mouth, changes in taste sensations,
dental decay, damage to small
blood vessels, and the risk
of necrosis to bone tissue.
- Chemotherapy.
Chemotherapy is dependent on
the cancer diagnosis. Therapy
can be designed for a systemic
approach (one that treats the
entire body) or a regional
approach (one that treats the
only the area of the cancer).
The appropriate medication
and duration of treatment is
determined by evaluating the
location of the cancer and
the severity of the disease
process. There are many side
effects to chemotherapy, including
complications affecting cells
of the bone marrow, the gut,
and lining of the mouth.
Treatment of most cancers
of the head and neck involve a combination
of surgery, radiation and chemotherapy.
DEVELOPMENTAL
DISORDERS OF THE HEAD
Developmental
disorders of the head (craniofacial
region) are the result of problems
that occur during development and
growth of a baby prior to birth.
Genes responsible for formation
of the head very early in pregnancy
(approximately three weeks following
conception) are also responsible
for the development of limbs and
vital organs, such as the heart
and lungs. Therefore, craniofacial
defects are many times components
of other developmental defects.
Many studies conclude that developmental
defects result from the interaction
of multiple genes and environmental
factors.
DESCRIPTION
OF SELECTED DEVELOPMENTAL DEFECTS
Cleft Lip
and Cleft Palate.
The most common of all craniofacial
defects is the cleft lip and cleft
palate. Clefting, or incomplete
fusion of the lip and/or palate,
can occur alone or as part of a
hereditary syndrome. The pattern
of inheritance in cleft lip and
cleft palate suggests that up to
twenty genes are involved with this
defect.
Craniosynostoses.
Craniosynostoses is a genetic disorder
that causes early fusion of the
bones surrounding and protecting the brain (bones of the skull).
As a result, dangerous amounts of
pressure are created against an
enlarging brain within a braincase
that is not growing. Several hereditary
syndromes include mental retardation
due to craniosynostoses as a characteristic
feature.
Hereditary
Anodontia. Conditions of
the complete absence of teeth (anodontia)
have been correlated to specific
genes. The complete absence of teeth
alters bone development within the
upper and lower jaws of the mouth.
Amelogenesis
Imperfecta and Dentinogenesis Imperfecta.
Amelogenesis imperfecta is a genetic
disorder that results in defective
enamel formation of teeth. Enamel
is the hard surface covering the
crowns of teeth. Amelogenesis imperfecta
either causes problems in enamel
hardening (mineralization) of normal
amounts of enamel or causes a smaller
amount of normal enamel to be produced.
Dentinogenesis imperfecta is a genetic
disorder that results in defective
dentin formation within teeth. Dentin
is a mineralized material forming
the bulk of each tooth. Defective
dentin causes the normal enamel
layer that covers the tooth to flake off.
In both diseases, the teeth are
weak and very sensitive to temperature
and pressures. Amelogenesis imperfecta
and dentinogenesis imperfecta are
linked to defects in structural
genes that code for proteins necessary
for the development of enamel and
dentin.
Osteogenesis
Imperfecta. Osteogenesis
imperfecta is an inherited disease
caused by mutations of genes that
produce collagen. Collagen is an
important substance within connective
tissues of the body such as bone.
Osteogenesis imperfecta causes 'brittle
bone' diseases that affect all bones
of the body. A complication of osteogenesis
imperfecta that involves tissues
of the mouth in addition to the
more generalized effect of fragile
bones is a painful dentinogenesis
imperfecta-like change in the teeth.
REFERENCES
Blot, W.J., J.K.
McLaughlin, D.M. Winn, D.F. Austin,
R.S. Greenberg, S. Preston-Martin,
L. Bernstein, J.B. Schoenberg, A.
Stemhagen, and J.F. Fraumeni. 1988.
Smoking and drinking in relation
to oral and pharyngeal cancer. Cancer
Research 48:3282-3287.
Bricker, S.L., R.P. Langlais
and C.S. Miller. 1994. Oral Diagnosis,
Oral Medicine, and Treatment Planning,
Second Edition. Philadelphia, Lea
and Febiger Publishing.
Greenblatt, M.S., W.P.
Bennett, M. Hollstein, C.C. Harris.
1994. Mutations in the p53 tumor
suppressor gene: clues to cancer
etiology and molecular pathogenesis.
Cancer Research 54(18):4855-4878.
Lidral, A.C., J.C. Murray,
K.H. Buetow, A.M. Basart, H. Schearer,
R. Schiang, A. Naval, E. Layda,
K. Magee, W. Magee. 1997. Studies
of the candidate genes TGFB2, MSX1,
TGFA, and TGFB3 in the etiology
of cleft lip and palate in the Philippines.
Cleft Palate - Craniofacial Journal
34(1):1-6.
Shklar G. 1986. Oral
Leukoplakia. New England Journal
of Medicine 315(24):1544-1546.
Spandidos D.A. A. Lamothe,
J.K. Field. 1985. Multiple transcriptional
activation of cellular oncogenes
in human head and neck solid tumors.
Anticancer Research 5(2):221-224.
U.S. Department of Health
and Human Services. 2000. Oral Health
in America: A Report of the Surgeon
General. U.S. Public Health Service.
HOW TO LEARN
MORE
www.ADA.org
This is the American Dental Association
website, which provides access to
news and publications related to
dental health
www.aaoms.org
This is the American Association
of Oral and Maxillofacial Surgeon
website, which contains information
about oral and maxillofacial surgery
including oral cancer.
www.tonguecancer.com
This site provides diagnosis and
treatment for cancers of the head
and neck.
www.clapa.cwc.net
This is the Cleft Lip and Palate
Association website, which provides
information and support to anyone
with or affected by cleft lip and
clept palate
www.cleftline.org
This is the American Cleft Palate-Craniofacial
Association website. This national
organization provides lay and professional
services for cleft lip, cleft palate,
and other craniofacial defects.
ABOUT THE AUTHOR
S. Michele Robichaux,
D.D.S, is an associate professor
of biology at Nicholls State University
in Thibodaux, Louisiana. She teaches
Human Anatomy, Physiology and Histology.
Her research interests include the
genetics and microbiology of periodontal
disease.
CONTACT THE
AUTHOR
Dr. S. Michele
Robichaux
Department of Biological Sciences
Nicholls State University
Thibodaux, LA 70310
(985) 448-4721
biol-smr@nicholls.edu

About the
Photos
Contact
Webmaster I LSUHSC
Home I Privacy
Policy I Disclaimer
|